Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study

Clinical Nutrition

Volumn 35, Issue 5, 2016, Pages 1110-1117

  Ezeamama, Amara Esther ^a   Guwatudde, David ^b   Wang, Molin ^c   Bagenda, Danstan ^b,c   Kyeyune, Rachel ^b   Sudfeld, Christopher ^c   Manabe, Yukari C ^b,d   Fawzi, Wafaie W ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; CD4+; HIV; Immune recovery; T cell count; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; EFAVIRENZ; NEVIRAPINE; VITAMIN D; 25-HYDROXYVITAMIN D;

ADULT; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D INSUFFICIENCY; VITAMIN D SUFFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; CONTROLLED STUDY; DIETARY SUPPLEMENT; FOLLOW UP; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SOCIOECONOMICS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84941709868     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2015.08.007     Document Type: Article

References (30)

1. [1] Jarvis, J.N., Bicanic, T., Loyse, A., Meintjes, G., Hogan, L., Roberts, C.H., et al. Very low levels of 25-Hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated Cryptococcal Meningitis. Clin Infect Dis 59:4 (2014 Aug 15), 493–500, 10.1093/cid/ciu349 Epub 2014 May 13.
2. [2] Banda, R., Mhemedi, B., Allain, T.J., Prevalence of vitamin D deficiency in adult tuberculosis patients at a central hospital in Malawi. Int J Tuberc Lung Dis 15 (2011), 408–410.
3. [3] Conesa-Botella, A., Goovaerts, O., Massinga-Loembe, M., Worodria, W., Mazakpwe, D., Luzinda, K., et al. Low prevalence of vitamin D deficiency in Ugandan HIV-infected patients with and without tuberculosis. Int J Tuberc Lung Dis 16 (2012), 1517–1521.
4. [4] Mastala, Y., Nyangulu, P., Banda, R.V., Mhemedi, B., White, S.A., Allain, T.J., Vitamin D deficiency in medical patients at a central hospital in Malawi: a comparison with TB patients from a previous study. PLoS One, 8, 2013 e59017.
5. [5] Sudfeld, C.R., Wang, M., Aboud, S., Giovannucci, E.L., Mugusi, F.M., Fawzi, W.W., Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy. PLoS One, 7, 2012 e40036.
6. [6] Villamor, E., A potential role for vitamin D on HIV infection?. Nutr Rev 64 (2006), 226–233.
7. [7] Lake, J.E., Adams, J.S., Vitamin D in HIV-infected patients. Curr HIV/AIDS Rep 8 (2011), 133–141.
8. [8] Havers, F.P., Detrick, B., Cardoso, S.W., Berendes, S., Lama, J.R., Sugandhavesa, P., et al. Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings. PLoS One, 9, 2014 e95164.
9. [9] von Essen, M.R., Kongsbak, M., Schjerling, P., Olgaard, K., Odum, N., Geisler, C., Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 11 (2010), 344–349.
10. [10] Viard, J.P., Souberbielle, J.C., Kirk, O., Reekie, J., Knysz, B., Losso, M., et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 25 (2011), 1305–1315.
11. [11] Mehta, S., Mugusi, F.M., Spiegelman, D., Villamor, E., Finkelstein, J.L., Hertzmark, E., et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS 25 (2011), 579–585.
12. [12] Ross, A.C., Judd, S., Kumari, M., Hileman, C., Storer, N., Labbato, D., et al. Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir Ther 16 (2011), 555–563.
13. [13] Kakalia, S., Sochett, E.B., Stephens, D., Assor, E., Read, S.E., Bitnun, A., Vitamin D supplementation and CD4 count in children infected with human immunodeficiency virus. J Pediatr 159 (2011), 951–957.
14. [14] Havers, F., Smeaton, L., Gupte, N., Detrick, B., Bollinger, R.C., Hakim, J., et al. 25-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings. J Infect Dis 210 (2014), 244–253.
15. [15] Guwatudde, D., Ezeamama, A.E., Bagenda, D., Kyeyune, R., Wabwire-Mangen, F., Wamani, H., et al. Multivitamin supplementation in HIV infected adults initiating antiretroviral therapy in Uganda: the protocol for a randomized double blinded placebo controlled efficacy trial. BMC Infect Dis, 12, 2012, 304.
16. [16] WHO, Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Department of Nutrition for Health and Development VaMNIS, 2011, World Health Organization, Geneva.
17. [17] Nansera, D., Graziano, F.M., Friedman, D.J., Bobbs, M.K., Jones, A.N., Hansen, K.E., Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberc Lung Dis 15 (2011), 1522–1527 i.
18. [18] Legeai, C., Vigouroux, C., Souberbielle, J.C., Bouchaud, O., Boufassa, F., Bastard, J.P., et al. Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 <> cohort study. PLoS One, 8, 2013 e74868.
19. [19] Bearden, A., Abad, C., Gangnon, R., Sosman, J.M., Binkley, N., Safdar, N., Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults. J Clin Endocrinol Metab 98 (2013), 1726–1733.
20. [20] Aziz, M., Livak, B., Burke-Miller, J., French, A.L., Glesby, M.J., Sharma, A., et al. Vitamin D insufficiency may impair CD4 recovery among women's interagency HIV Study participants with advanced disease on HAART. AIDS 27 (2013), 573–578.
21. [21] Van Den Bout-Van Den Beukel, C.J., Fievez, L., Michels, M., Sweep, F.C., Hermus, A.R., Bosch, M.E., et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 24 (2008), 1375–1382.
22. [22] Lang, P.O., Aspinall, R., Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response?. Nutrients 7 (2015), 2044–2060.
23. [23] Ezeamama, A.E., Mupere, E., Oloya, J., Martinez, L., Kakaire, R., Yin, X., et al. Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV-tuberculosis co-infected patients on combination antiretroviral therapy. Int J Infect Dis 35 (2015), 73–79.
24. [24] Gui, J., Mustachio, L.M., Su, D.M., Craig, R.W., Thymus size and age-related thymic involution: early programming, sexual dimorphism, progenitors and stroma. Aging Dis 3 (2012), 280–290.
25. [25] Marcos, A., Nova, E., Montero, A., Changes in the immune system are conditioned by nutrition. Eur J Clin Nutr 57:Suppl. 1 (2003), S66–S69.
26. [26] Keith, M.E., Jeejeebhoy, K.N., Immunonutrition. Baillieres Clin Endocrinol Metab 11 (1997), 709–738.
27. [27] Papparella, I., Ceolotto, G., Berto, L., Cavalli, M., Bova, S., Cargnelli, G., et al. Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res 73 (2007), 432–438.
28. [28] Munteanu, A., Ricciarelli, R., Zingg, J.M., HIV protease inhibitors-induced atherosclerosis: prevention by alpha-tocopherol. IUBMB Life 56 (2004), 629–631.
29. [29] Abrams, B., Duncan, D., Hertz-Picciotto, I., A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. J Acquir Immune Defic Syndr 6 (1993), 949–958.
30. [30] Tang, A.M., Graham, N.M., Kirby, A.J., McCall, L.D., Willett, W.C., Saah, A.J., Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 138 (1993), 937–951.